These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21724358)

  • 1. Assessment of colorectal hepatic metastases by quantitative T2 relaxation time.
    Raza SA; Funicelli L; Sohaib SA; Collins DJ; Scurr E; Leach MO; Koh DM
    Eur J Radiol; 2012 Apr; 81(4):e536-40. PubMed ID: 21724358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of self-gated and prospectively triggered fast low angle shot (FLASH) sequences for contrast-enhanced magnetic resonance imaging of the liver at 9.4 T in a rat model of colorectal cancer metastases.
    Fries P; Seidel R; Müller A; Matthes K; Denda G; Massmann A; Menger MD; Sperling J; Morelli JN; Altmeyer K; Schneider G; Buecker A
    Invest Radiol; 2013 Oct; 48(10):738-44. PubMed ID: 23695083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of hepatocellular carcinoma and hepatic metastasis from cysts and hemangiomas with calculated T2 relaxation times and the T1/T2 relaxation times ratio.
    Farraher SW; Jara H; Chang KJ; Ozonoff A; Soto JA
    J Magn Reson Imaging; 2006 Dec; 24(6):1333-41. PubMed ID: 17083093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases' response to radiofrequency ablation.
    Szurowska E; Nowicki TK; Izycka-Swieszewska E; Zadrozny D; Markiet K; Studniarek M
    J Magn Reson Imaging; 2013 Nov; 38(5):1027-32. PubMed ID: 23526807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility and biological basis of in vivo T(2)* magnetic resonance imaging of liver metastasis of colorectal cancer.
    Ter Voert EG; Heijmen L; de Wilt JH; Bussink J; Punt CJ; van Laarhoven HW; Heerschap A
    Magn Reson Med; 2013 Oct; 70(4):1145-52. PubMed ID: 23165899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
    AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
    [No Abstract]   [Full Text] [Related]  

  • 7. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
    Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
    J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
    Granata V; Fusco R; Catalano O; Filice S; Amato DM; Nasti G; Avallone A; Izzo F; Petrillo A
    PLoS One; 2015; 10(11):e0142876. PubMed ID: 26566221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
    Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases.
    Zhang H; Li W; Hu F; Sun Y; Hu T; Tong T
    Abdom Radiol (NY); 2019 Jan; 44(1):65-71. PubMed ID: 29967982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysis.
    Coenegrachts K; Bols A; Haspeslagh M; Rigauts H
    Eur J Radiol; 2012 Dec; 81(12):3870-6. PubMed ID: 22944331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference.
    Wagner M; Maggiori L; Ronot M; Paradis V; Vilgrain V; Panis Y; Van Beers BE
    Eur Radiol; 2013 Aug; 23(8):2156-64. PubMed ID: 23455763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced respiratory motion artifacts using structural similarity in fast 2D dynamic contrast enhanced MRI of liver lesions.
    Ter Voert EE; Heijmen L; Punt CJ; de Wilt JH; van Laarhoven HW; Heerschap A
    NMR Biomed; 2016 Nov; 29(11):1526-1535. PubMed ID: 27598946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging.
    Jia G; O'Dell C; Heverhagen JT; Yang X; Liang J; Jacko RV; Sammet S; Pellas T; Cole P; Knopp MV
    Radiology; 2008 Sep; 248(3):901-9. PubMed ID: 18710983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2-weighted MR imaging of the liver: qualitative and quantitative comparison of SPACE MR imaging with turbo spin-echo MR imaging.
    Dohan A; Gavini JP; Placé V; Sebbag D; Vignaud A; Herbin C; Hamzi L; Boudiaf M; Soyer P
    Eur J Radiol; 2013 Nov; 82(11):e655-61. PubMed ID: 23957939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence.
    Said B; McCart JA; Libutti SK; Choyke PL
    Magn Reson Imaging; 2000 Apr; 18(3):305-9. PubMed ID: 10745140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of three different cardiac T
    Baeßler B; Schaarschmidt F; Stehning C; Schnackenburg B; Giolda A; Maintz D; Bunck AC
    J Magn Reson Imaging; 2016 Nov; 44(5):1168-1178. PubMed ID: 27043352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.